GLIS1 intervention enhances anti-PD1 therapy for hepatocellular carcinoma by targeting SGK1-STAT3-PD1 pathway
暂无分享,去创建一个
Yongxiang Xia | Weiwei Tang | Ziyi Chen | Guoqiang Sun | Li Liu | Guangshun Sun | Hanyuan Liu | Junwei Kang | D. Rong | Xuehao Wang | Yuliang Wang | Xiaopei Hao | Tian Huang | Zhiying Zheng | H. Cao